Levetiracetam AET 250 mg Filmdragerad tablett

Država: Švedska

Jezik: švedski

Izvor: Läkemedelsverket (Medical Products Agency)

Uputa o lijeku Uputa o lijeku (PIL)
21-04-2018
Svojstava lijeka Svojstava lijeka (SPC)
21-04-2018

Aktivni sastojci:

levetiracetam

Dostupno od:

Alfred E Tiefenbacher (GmbH & Co. KG)

ATC koda:

N03AX14

INN (International ime):

levetiracetam

Doziranje:

250 mg

Farmaceutski oblik:

Filmdragerad tablett

Sastav:

levetiracetam 250 mg Aktiv substans

Razred:

Apotek

Tip recepta:

Receptbelagt

Područje terapije:

Levetiracetam

Status autorizacije:

Avregistrerad

Datum autorizacije:

2012-04-12

Uputa o lijeku

                                PACKAGE LEAFLET: INFORMATION FOR THE
PATIENT
LEVETIFI 250 MG FILM-COATED TABLETS
LEVETIFI 500 MG FILM-COATED TABLETS
LEVETIFI 750 MG FILM-COATED TABLETS
LEVETIFI 1000 MG FILM-COATED TABLETS
levetiracetam
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU OR YOUR CHILD START
TAKING THIS MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Levetifi is and what it is used for
2.
What you need to know before you take Levetifi
3.
How to take Levetifi
4.
Possible side effects
5.
How to store Levetifi
6.
Contents of the pack and other information
1.
WHAT LEVETIFI IS AND WHAT IT IS USED FOR
Levetiracetam is an antiepileptic medicine (a medicine used to treat
seizures in epilepsy).
Levetifi is used:

on its own in adults and adolescents from 16 years of age with newly
diagnosed
epilepsy, to treat a certain form of epilepsy. Epilepsy is a condition
where the patients
have repeated fits (seizures). Levetiracetam is used for the epilepsy
form in which the
fits initially affect only one side of the brain, but could thereafter
extend to larger
areas on both sides of the brain (partial onset seizure with or
without secondary
generalisation). Levetiracetam has been given to you by your doctor to
reduce the
number of fits.

as an add-on to other antiepileptic medicines to treat:

partial onset seizures with or without generalisation in adults,
adolescents, children
and infants from one month of age;

myoclonic seizures (short, shock-like jerks of a muscle or group of
muscles) in
adults and adolescents from 12 years of age with juvenile myoclonic
epilepsy;

primary gene
                                
                                Pročitajte cijeli dokument
                                
                            

Svojstava lijeka

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Pročitajte cijeli dokument
                                
                            

Dokumenti na drugim jezicima

Uputa o lijeku Uputa o lijeku engleski 14-06-2019
Svojstava lijeka Svojstava lijeka engleski 14-06-2019
Izvješće o ocjeni javnog Izvješće o ocjeni javnog engleski 04-02-2013

Upozorenja za pretraživanje vezana za ovaj proizvod